Toll at 12 dead in Canada Legionnaire's disease outbreak

The death toll from an outbreak of Legionnaire's disease in Quebec City has risen to 12 since late July, health authorities in the Canadian city said Tuesday.

Officials said that 176 people have so far been diagnosed with the disease, which poses a risk for people with weak immune systems but can be treated with antibiotics.

Officials suspect improper maintenance of air conditioning systems as the cause of the outbreak.

Legionella bacteria grow in stagnant water, then spread as droplets are expelled by the appliances.

The illness, which has an of between two and 10 days, is an infection that causes , and pneumonia.

The disease was discovered in the United States in 1976 during a convention of the American Legion, an military veterans group, where 29 people died.

Related Stories

US says Legionnaires cases triple over decade

date Aug 18, 2011

(AP) -- Cases of Legionnaires' disease have tripled in the last decade, U.S. health officials said Thursday, but the risk of dying from it is lower because of more effective treatment.

Hong Kong probes deadly bug at government offices

date Jan 04, 2012

Hong Kong officials said Wednesday the discovery of a bacteria that cause Legionnaires' disease at the new government complex was "under control", while it was probing the source of the deadly bug. ...

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 13 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date 23 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 23 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.